Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Annals of Hematology|July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter studyWon Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Annals of Hematology|December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neckHan Sang Kim, Hyeong Ju Kwon, Inkyung Jung, et al.
The New England Journal of Medicine|December 8, 2025
Dual Targeting of Extramedullary Myeloma with Talquetamab and TeclistamabShaji Kumar, María-Victoria Mateos, Jing Christine Ye, et al.
Frontiers in Oncology|September 7, 2023
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantationSeok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, et al.
The Lancet. Oncology|February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisSeok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.
Oncotarget|December 2, 2017
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphomaJunshik Hong, Seok Jin Kim, Myung Hee Chang, et al.
Oncotarget|October 8, 2016
Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort studySeok Jin Kim, Jun Sik Hong, Myung Hee Chang, et al.
Cancer Research and Treatment|April 25, 2022
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean CohortsJun Ho Yi, Seong Hyun Jeong, Seok Jin Kim, et al.
Cancer Research and Treatment|January 6, 2022
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort StudySeong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, et al.
Pageof 27